Pfizer Inc. (PFE) and BioNTech SE’s (BNTX) COVID-19 vaccine received approval from the European Union’s regulatory authority for children between the ages of 5 and 11. The approval will in aid the mitigation of the accelerated rise in COVID-19 cases in Europe. Shares closed at $50.89 on November 25. According to Reuters, the European Medicines Agency (EMA) has approved the vaccine, Comirnaty, as an injection (in the upper arm) in two 10 microgram doses, to be administered three weeks apart . In a clinical trial of children between the ages of 5-11 years, Pfizer and BioNTech said that their vaccine demonstrated 90.7% efficacy against the coronavirus.
https://www.tipranks.com/news/eu-approves-pfizers-covid-19-vaccine-for-ages-5-to-11?utm_source=advfn.com&utm_medium=referral
Pfizer (NYSE:PFE)
過去 株価チャート
から 12 2021 まで 1 2022 Pfizerのチャートをもっと見るにはこちらをクリック
Pfizer (NYSE:PFE)
過去 株価チャート
から 1 2021 まで 1 2022 Pfizerのチャートをもっと見るにはこちらをクリック